West Pharmaceutical Services Cash on Hand 2010-2022 | WST

West Pharmaceutical Services cash on hand from 2010 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • West Pharmaceutical Services cash on hand for the quarter ending June 30, 2022 was $0.719B, a 24.7% increase year-over-year.
  • West Pharmaceutical Services cash on hand for 2021 was $0.763B, a 23.9% increase from 2020.
  • West Pharmaceutical Services cash on hand for 2020 was $0.616B, a 40.17% increase from 2019.
  • West Pharmaceutical Services cash on hand for 2019 was $0.439B, a 30.14% increase from 2018.
West Pharmaceutical Services Annual Cash on Hand
(Millions of US $)
2021 $763
2020 $616
2019 $439
2018 $337
2017 $236
2016 $203
2015 $275
2014 $255
2013 $230
2012 $174
2011 $118
2010 $110
2009 $83
West Pharmaceutical Services Quarterly Cash on Hand
(Millions of US $)
2022-06-30 $719
2022-03-31 $668
2021-12-31 $763
2021-09-30 $688
2021-06-30 $576
2021-03-31 $484
2020-12-31 $616
2020-09-30 $519
2020-06-30 $446
2020-03-31 $335
2019-12-31 $439
2019-09-30 $396
2019-06-30 $327
2019-03-31 $266
2018-12-31 $337
2018-09-30 $297
2018-06-30 $226
2018-03-31 $200
2017-12-31 $236
2017-09-30 $269
2017-06-30 $227
2017-03-31 $169
2016-12-31 $203
2016-09-30 $206
2016-06-30 $203
2016-03-31 $178
2015-12-31 $275
2015-09-30 $257
2015-06-30 $252
2015-03-31 $207
2014-12-31 $255
2014-09-30 $247
2014-06-30 $227
2014-03-31 $230
2013-12-31 $230
2013-09-30 $229
2013-06-30 $198
2013-03-31 $183
2012-12-31 $174
2012-09-30 $165
2012-06-30 $133
2012-03-31 $127
2011-12-31 $118
2011-09-30 $119
2011-06-30 $110
2011-03-31 $95
2010-12-31 $110
2010-09-30 $97
2010-06-30 $68
2010-03-31 $66
2009-12-31 $83
2009-09-30 $80
2009-06-30 $87
2009-03-31 $66
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $25.090B $2.832B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $73.740B 21.42
McKesson (MCK) United States $51.687B 15.01
AmerisourceBergen (ABC) United States $30.494B 13.47
Laboratory Of America Holdings (LH) United States $24.019B 10.51
Cardinal Health (CAH) United States $17.095B 13.13
Cooper (COO) United States $16.392B 25.23
CONMED (CNMD) United States $3.073B 30.28
Invacare (IVC) United States $0.035B 0.00